| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | 0.078 | 0.8 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | 0.0091 | 0.8 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.8 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.8 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.0093 | 0.8 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.0094 | 0.8 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |